Form D · Biotechnology

ImCare Biotech, Inc.

Doylestown, PA · CIK 0001806270

Offering snapshot reported Jul 14, 2023 · SEC filing

Reported sold
$153K
Offering amount: $153K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 5, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 14, 2023Initial$153,402No comparison1SEC filing
Apr 13, 2022Initial$368,415No comparison1SEC filing
Jul 27, 2021Initial$1,278,351No comparisonNot reportedSEC filing
May 4, 2021Initial$1,777,419No comparisonNot reportedSEC filing
Mar 12, 2020Initial$680,150No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-486928

Source: Form D, filed Jul 14, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Frank Fischer Director
Matthew Lee Director
Aaron Lu Director, Executive
Felix Y. Lu Director, Executive
Xuanyong Lu Director, Executive
Xuanyong Lu, Ph D Director, Executive
Lizhu Tang Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3805 Old Easton Road
Doylestown, PA, 18902